Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity. / O'Keefe, Stephen J D; Rakitt, Tina; Ou, Junhai; El Hajj, Ihab I; Blaney, Elizabeth; Vipperla, Kishore; Holst, Jens-Jules; Rehlfeld, Jens.

In: Clinical and Translational Gastroenterology, Vol. 8, e112, 03.08.2017.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

O'Keefe, SJD, Rakitt, T, Ou, J, El Hajj, II, Blaney, E, Vipperla, K, Holst, J-J & Rehlfeld, J 2017, 'Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity', Clinical and Translational Gastroenterology, vol. 8, e112. https://doi.org/10.1038/ctg.2017.39

APA

O'Keefe, S. J. D., Rakitt, T., Ou, J., El Hajj, I. I., Blaney, E., Vipperla, K., Holst, J-J., & Rehlfeld, J. (2017). Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity. Clinical and Translational Gastroenterology, 8, [e112]. https://doi.org/10.1038/ctg.2017.39

Vancouver

O'Keefe SJD, Rakitt T, Ou J, El Hajj II, Blaney E, Vipperla K et al. Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity. Clinical and Translational Gastroenterology. 2017 Aug 3;8. e112. https://doi.org/10.1038/ctg.2017.39

Author

O'Keefe, Stephen J D ; Rakitt, Tina ; Ou, Junhai ; El Hajj, Ihab I ; Blaney, Elizabeth ; Vipperla, Kishore ; Holst, Jens-Jules ; Rehlfeld, Jens. / Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity. In: Clinical and Translational Gastroenterology. 2017 ; Vol. 8.

Bibtex

@article{5e1cf45c1fe64ddb8f7c08e91e09a53a,
title = "Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity",
abstract = "OBJECTIVES: Despite the fact that the most effective treatment for morbid obesity today is gastric bypass surgery, some patients develop life-threatening nutritional complications associated with their weight loss.METHODS: Here we examine the influence of the altered anatomy and digestive physiology on pancreatic secretion and fat absorption. Thirteen post Roux-en-Y gastric bypass (RYGB) patients who had lost >100 lbs in the first year following surgery and who gave variable histories of gastrointestinal (GI) dysfunction, were selected for study. Food-stimulated pancreatic enzyme secretion and GI hormone responses were measured during 2 h perfusions of the Roux limb with a standard polymeric liquid formula diet and polyethylene glycol marker, with collections of secretions from the common channel distal to the anastomosis and blood testing. Fat absorption was then measured during a 72 h balance study when a normal diet was given containing ~100 g fat/d.RESULTS: Result showed that all patients had some fat malabsorption, but eight had coefficients of fat absorption <80%, indicative of steatorrhea. This was associated with significantly lower feed-stimulated secretion rates of trypsin, amylase, and lipase, and higher plasma peptide-YY concentrations compared with healthy controls. Five steatorrhea patients were subsequently treated with low quantities of pancreatic enzyme supplements for 3 months, and then retested. The supplements were well tolerated, and fat absorption improved in four of five patients accompanied by an increase in lipase secretion, but body weight increased in only three. Postprandial breath hydrogen concentrations were elevated with some improvement following enzyme supplementation suggesting persistent bacterial overgrowth and decreased colonic fermentation.CONCLUSIONS: Our investigations revealed a wide spectrum of gastrointestinal abnormalities, including fat malabsorption, impaired food stimulated pancreatic secretion, ileal brake stimulation, and bacterial overgrowth, in patients following RYGB which could be attributed to the breakdown of the normally highly orchestrated digestive anatomy and physiology.",
keywords = "Journal Article",
author = "O'Keefe, {Stephen J D} and Tina Rakitt and Junhai Ou and {El Hajj}, {Ihab I} and Elizabeth Blaney and Kishore Vipperla and Jens-Jules Holst and Jens Rehlfeld",
year = "2017",
month = aug,
day = "3",
doi = "10.1038/ctg.2017.39",
language = "English",
volume = "8",
journal = "Clinical and Translational Gastroenterology",
issn = "2155-384X",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity

AU - O'Keefe, Stephen J D

AU - Rakitt, Tina

AU - Ou, Junhai

AU - El Hajj, Ihab I

AU - Blaney, Elizabeth

AU - Vipperla, Kishore

AU - Holst, Jens-Jules

AU - Rehlfeld, Jens

PY - 2017/8/3

Y1 - 2017/8/3

N2 - OBJECTIVES: Despite the fact that the most effective treatment for morbid obesity today is gastric bypass surgery, some patients develop life-threatening nutritional complications associated with their weight loss.METHODS: Here we examine the influence of the altered anatomy and digestive physiology on pancreatic secretion and fat absorption. Thirteen post Roux-en-Y gastric bypass (RYGB) patients who had lost >100 lbs in the first year following surgery and who gave variable histories of gastrointestinal (GI) dysfunction, were selected for study. Food-stimulated pancreatic enzyme secretion and GI hormone responses were measured during 2 h perfusions of the Roux limb with a standard polymeric liquid formula diet and polyethylene glycol marker, with collections of secretions from the common channel distal to the anastomosis and blood testing. Fat absorption was then measured during a 72 h balance study when a normal diet was given containing ~100 g fat/d.RESULTS: Result showed that all patients had some fat malabsorption, but eight had coefficients of fat absorption <80%, indicative of steatorrhea. This was associated with significantly lower feed-stimulated secretion rates of trypsin, amylase, and lipase, and higher plasma peptide-YY concentrations compared with healthy controls. Five steatorrhea patients were subsequently treated with low quantities of pancreatic enzyme supplements for 3 months, and then retested. The supplements were well tolerated, and fat absorption improved in four of five patients accompanied by an increase in lipase secretion, but body weight increased in only three. Postprandial breath hydrogen concentrations were elevated with some improvement following enzyme supplementation suggesting persistent bacterial overgrowth and decreased colonic fermentation.CONCLUSIONS: Our investigations revealed a wide spectrum of gastrointestinal abnormalities, including fat malabsorption, impaired food stimulated pancreatic secretion, ileal brake stimulation, and bacterial overgrowth, in patients following RYGB which could be attributed to the breakdown of the normally highly orchestrated digestive anatomy and physiology.

AB - OBJECTIVES: Despite the fact that the most effective treatment for morbid obesity today is gastric bypass surgery, some patients develop life-threatening nutritional complications associated with their weight loss.METHODS: Here we examine the influence of the altered anatomy and digestive physiology on pancreatic secretion and fat absorption. Thirteen post Roux-en-Y gastric bypass (RYGB) patients who had lost >100 lbs in the first year following surgery and who gave variable histories of gastrointestinal (GI) dysfunction, were selected for study. Food-stimulated pancreatic enzyme secretion and GI hormone responses were measured during 2 h perfusions of the Roux limb with a standard polymeric liquid formula diet and polyethylene glycol marker, with collections of secretions from the common channel distal to the anastomosis and blood testing. Fat absorption was then measured during a 72 h balance study when a normal diet was given containing ~100 g fat/d.RESULTS: Result showed that all patients had some fat malabsorption, but eight had coefficients of fat absorption <80%, indicative of steatorrhea. This was associated with significantly lower feed-stimulated secretion rates of trypsin, amylase, and lipase, and higher plasma peptide-YY concentrations compared with healthy controls. Five steatorrhea patients were subsequently treated with low quantities of pancreatic enzyme supplements for 3 months, and then retested. The supplements were well tolerated, and fat absorption improved in four of five patients accompanied by an increase in lipase secretion, but body weight increased in only three. Postprandial breath hydrogen concentrations were elevated with some improvement following enzyme supplementation suggesting persistent bacterial overgrowth and decreased colonic fermentation.CONCLUSIONS: Our investigations revealed a wide spectrum of gastrointestinal abnormalities, including fat malabsorption, impaired food stimulated pancreatic secretion, ileal brake stimulation, and bacterial overgrowth, in patients following RYGB which could be attributed to the breakdown of the normally highly orchestrated digestive anatomy and physiology.

KW - Journal Article

U2 - 10.1038/ctg.2017.39

DO - 10.1038/ctg.2017.39

M3 - Journal article

C2 - 28771242

VL - 8

JO - Clinical and Translational Gastroenterology

JF - Clinical and Translational Gastroenterology

SN - 2155-384X

M1 - e112

ER -

ID: 182619895